Office of Texas A.G.'s Civil Medicaid Fraud Division Recovers $42.7 Million in Taxpayer Funds
August 09, 2023
August 09, 2023
AUSTIN, Texas, Aug. 9 -- The Office of the Attorney General of Texas issued the following news release:
The Office of the Attorney General's ("OAG") Civil Medicaid Fraud Division settled an enforcement action brought under the Texas Medicaid Fraud Prevention Act ("TMFPA") against pharmaceutical drug manufacturers Shire PLC, Baxter International Inc., Baxalta Inc., Viropharma Inc., Takeda Pharmaceuticals U.S.A., Inc., and Takeda Pharmaceuticals America.
The Office of the Attorney General's ("OAG") Civil Medicaid Fraud Division settled an enforcement action brought under the Texas Medicaid Fraud Prevention Act ("TMFPA") against pharmaceutical drug manufacturers Shire PLC, Baxter International Inc., Baxalta Inc., Viropharma Inc., Takeda Pharmaceuticals U.S.A., Inc., and Takeda Pharmaceuticals America.